Also, the fact that two benign tumors - oncocytoma and non-invasive papillary urothelial pTaG2 low grade carcinoma - showed occasional E-Cadherin loss suggests that reduced or absent E-Cadherin immunostaining is not invariably linked to tumor malignancy. The gene discussed is CDH1; the disease is carcinoma.